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Abstract

Introduction: Approximately 9.4% of the US population has
diabetes, while about 85% of the US population consumes over a
100mg of caffeine daily. Whereas several epidemiological studies
indicate that long-term coffee consumption reduces the risk of
Type 2 diabetes mellitus (T2DM), the short-term effect of its
consumption on glycemic control and diabetic complications
warrants further elucidation. This is the focus of our research
inquiry.
Methods: The blood glucose levels of 21 healthy individuals
were measured using a glucometer after a carbohydrate-rich
meal. For the control trial, each individual’s blood glucose levels
was taken before the meal and then 15 mins, 45 mins, and 60
mins after eating the meal. For the experimental trial, each
individual repeated the control trial but 30 mins after consuming
caffeine. The meal was composed of a bagel, cream cheese, and a
glucose drink.
Results: There was a significant time-dependent change in blood
glucose levels during the control trial, F(2.980, 59.602) =
21.492, p< 0.0005. There was a statistically significant increase
in blood glucose levels with the caffeine trial - F(1, 20) =
5.830, p = 0.025.
Conclusion: Caffeine consumption with or about meal time
acutely impairs glucose tolerance by increasing the rate of spike
of blood glucose levels, decreased insulin sensitivity and
potentially increases the risk of β-cell dysfunction. In a diabetic
patient, this effect could make a tight blood glucose control
difficult to achieve therefore requiring higher doses of
hypoglycemic drugs and increasing the risk of diabetic
complications like diabetic retinopathy, neuropathy or ischemic
heart disease.

Results
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The blood glucose of 21 healthy individuals were measured using
a glucometer. For the control trial, each individual’s blood glucose
levels was taken before the meal and then 15 mins, 45 mins, and
60 mins after eating the meal. For the experimental trial, each
individual repeated the control trial but only 30min after the
consumption of caffeine. The meal was composed of a bagel,
cream cheese, and a glucose drink.

Conclusion

Figure 1. The blood glucose levels changed over time during the control trial, F(2.980,
59.602) = 21.492, p< 0.0005. The blood glucose levels increase significantly before they
gradually decline – the decline is due to the activity of insulin secreted in response to a
A
sudden spike in blood glucose level after food.

Figure 4. Caffeine consumption with a carbohydrate-rich meal produced a rate of
postprandial blood glucose spike that was twice that of the baseline trial. The implication
being that the strain on the pancreatic beta cells to secrete insulin will be much higher
with caffeine.
Prolonged pancreatic strain potentially induces beta cell apoptosis and insulin deficiency.

As opposed to the findings of several epidemiological studies on
the long-term effects of coffee consumption on insulin sensitivity
and risk of T2DM, our study suggests that;
1. Caffeine consumption with a carbohydrate-rich meal causes a
more rapid spike in blood glucose.
2. Caffeine acutely impairs glucose tolerance necessitation the use
of higher doses of oral hypoglycemic in T2DM patients.
3. Caffeine acutely increases insulin secretion but reduces insulin
sensitivity. This potentially increases the risk of diabetic
complications in T2DM patients.

Future Studies

The following studies will help consolidate our understanding of
the clinical implications of coffee consumption in a T2DM patient;
1. An evaluation of the incidence of complications in T2DM
coffee drinkers.
2. The acute and long-term effects of the other ingredients found
in coffee
3. The actual doses of oral hypoglycemic used to maintain
glycemic control in T2DM coffee drinkers.

Figure 2. Caffeine significantly increased blood glucose levels over a 60 minute post
prandial period - F(1, 20) = 5.830, p = 0.025.

Introduction
The postprandial spike in blood glucose levels initiates a glucosedependent secretion of insulin by the pancreatic beta cells which
promotes the rapid uptake of glucose by skeletal muscles and adipose
tissues consequently re-establishing euglycemia. These responses are
impaired in T2DM patients owing to a sustained elevation of counterregulatory hormones (like glucagon, epinephrine and cortisol) which
causes persistent hyperglycemia. Impaired glucose tolerance is
worsened by high glycemic index foods which cause a very rapid
postprandial spike in blood glucose levels. Caffeine, the major
component of coffee is a methylxanthine that has antagonistic
properties against adenosine receptors (A1 and A2) and has been
shown to cause elevations of plasma epinephrine levels.
Consequently, caffeine has the acute effects of promoting lipolysis
(increases release of free fatty acids into the bloodstream) and
gluconeogenesis. This elevation of epinephrine promotes insulin
resistance and in the context of the hyperglycemia and
hyperinsulinemia in the immediate postprandial period, how will
these counteracting biochemical activities affect the attainment of a
good blood glucose control and the development or prevention of
diabetic complications in a diabetic coffee drinker? This is the
research question that we sought to investigate in this study.

Methods
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Figure 5. The rate of blood glucose decline from the peak values in the caffeine trial was
2 times higher than the baseline trials. This suggests that caffeine consumption with the
meal elicited a much higher level of insulin secretion than the baseline trials.
This wide fluctuation in blood glucose levels poses a huge challenge to maintaining
euglycemia.
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Figure 3. Blood glucose levels peaked at the 15 minute mark which coincides with the
peak activity and plasma concentration of caffeine (45 minutes from the time of caffeine
consumption). This peak point also indicates the peak of insulin secretion.
Also note that the blood glucose level at the start and end of the experiment is higher
for the caffeine trial than baseline
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